Track: Basic

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-01 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Genetics
Track:	1 Basic
Session title:	Genetic strategies in the search for genes in schizophrenia
	Florence Thibaut, France	Chair
	Norio Ozaki, Japan	Co-Chair

001	DISC 1 interacting molecule and schizophrenia
	Norio Ozaki, Japan	Speaker
002	Genetic findings in schizophrenia and related intermediate phenotypes: New genes and pathways
	Dan Rujescu, Germany	Speaker
003	CAPON gene in schizophrenic Latin America population
	Jorge Ospina-Duque, Colombia	Speaker
004	Cognition guided genetics of schizophrenia
	Rainald Mössner, Germany	Speaker

No.	S-02 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Comparative neuropathology of schizophrenia and bipolar disorder
	Bernhard Bogerts, Germany	Chair
	Sabine Bahn, United Kingdom	Co-Chair

001	Peripheral biomarkers as indicators of brain pathology in schizophrenia and affective disorder
	Sabine Bahn, United Kingdom	Speaker
002	White matter abnormalities in schizophrenia and bipolar disorder
	Andrew Dwork, USA	Speaker
003	Immunohistochemical studies in schizophrenia and bipolar disorder
	Bernhard Bogerts, Germany	Speaker
004	Ultrastructural studies in schizophrenia and bipolar disorder
	Natalia Uranova, Russia	Speaker

No.	S-03 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	Serotonin receptors in endophenotypic variations and treatment of schizophrenia: Genetic, neurocognitive, and pharmacological perspectives
	Tomiki Sumiyoshi, Japan	Chair
	Vera Bubenikova-Valesova, Czech Republic	Co-Chair

001	Multimodal imaging genetics on serotonin receptor polymorphisms in schizophrenia
	Jiri Horacek, Czech Republic	Speaker
002	Improving cognitive function in animal models of schizophrenia: Focus on serotonin receptors
	Vera Bubenikova-Valesova, Czech Republic	Speaker
003	Learning and memory in 5-HT1A-receptor mutant mice
	Bettina Bert, Germany	Speaker
004	Serotonin-1A receptors and cognitive enhancement in schizophrenia: Evidence from translational research
	Tomiki Sumiyoshi, Japan	Speaker

No.	S-04 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Brain Function
Track:	1 Basic
Session title:	Social brain functions in schizophrenia and mood disorders
	Shigenobu Kanba, Japan	Chair
	Martin Brüne, Germany	Co-Chair

001	Charcterization of epathy deficits in psychiatric populations
	Simone Shamay-Tsoory, Israel	Speaker
002	Deficit in theory of mind predicts treatment outcome of depression
	Shigenobu Kanba, Japan	Speaker
003	Integrated approach of theory of mind and contextual processing deficits in schizophrenia: from neurocognitive deficits to clinical assessment
	Eric Brunet-Gouet, France	Speaker
004	Social cognition and deviant behavior in schizophrenia
	Martin Brüne, Germany	Speaker

No.	S-06 - Symposium
Time:	08.00-09.30
Room:	Room 251
Topic:	Psychopharmacology
Track:	1 Basic
Session title:	The endocannabinoid system in psychiatric disorders: From basic neuroscience to clinical practice
	F. Markus Leweke, Germany	Chair
	Daniele Piomelli, Italy	Co-Chair

001	Breakdown of cell assembly synchronization by CB1 receptor activation
	György Buzsaki, Hungary	Speaker
002	Endocannabinoids in anxiety and depression
	Daniele Piomelli, Italy	Speaker
003	eCB, processing reward-related stimuli and substance use disorders
	Rajita Sinha, USA	Speaker
004	Translational studies on eCBs in schizophrenia: Bench to bedside
	F. Markus Leweke, Germany	Speaker

No.	S-07 - Symposium
Time:	11.00-12.30
Room:	Blue Amphitheatre
Topic:	Genetics
Track:	1 Basic
Session title:	Gene-environment interactions in mental health: New paradigms in basic and clinical research
	Mikhail Pletnikov, USA	Chair
	Jim van Os, Netherlands	Co-Chair

001	How to model the environment in human GxE studies of psychosis
	Jim van Os, Netherlands	Speaker
002	Human G x E interactions in depression using experimental ecogenetic approaches
	Marieke Wichers, Netherlands	Speaker
003	Gene-environment interactions throughout development: Adaptability and resilience in monkey model
	Stephen Suomi, USA	Speaker
004	Gene-environment interactions in psychiatry: DISC1 mouse model
	Mikhail Pletnikov, USA	Speaker

No.	S-08 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Psychopharmacology
Track:	1 Basic
Session title:	Non-classical mechanisms of action of antidepressants
	Rainer Rupprecht, Germany	Chair
	Mark Rasenick, USA	Co-Chair

001	Role of lipid rafts for antidepressant induced G-protein signalling
	Mark Rasenick, USA	Speaker
002	Modulation of ligand-gated ion channels by antidepressants
	Rainer Rupprecht, Germany	Speaker
003	Role of P-glycoprotein for HPA axis activity and antidepressant treatment
	Carmine Pariante, United Kingdom	Speaker
004	5-HT6 receptor stimulation regulates excitatory and inhibitory neurotransmission and induces neuronal plasticity: Potential mechanisms for antidepressant drug action and neuroprotection
	Lee Schechter, USA	Speaker

No.	S-09 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Anxiety
Track:	1 Basic
Session title:	Glutamate as a neurobiological target in anxiety disorders: Metabotropic or ionotropic receptors?
	Brian Harvey, South Africa	Chair
	Mohammed Shahid, United Kingdom	Co-Chair

001	Role of the glutamate system in the neurobiology of anxiety and stress related disorders: How strong is the therapeutic rationale?
	S.J. Mathew, USA	Speaker
002	Role of animal models in the development of current and novel therapeutic strategies for anxiety disorders
	John Cryan, Ireland	Speaker
003	Targeting metabotropic glutamate receptors: Evidence to support pharmacological validation in anxiety and stress disorders
	Andrzej Pilc, Poland	Speaker
004	Targeting ionotropic glutamate receptors: Therapeutic rationale in anxiety and stress disorders
	Wojciech Danysz, Germany	Speaker

No.	S-10 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	Disturbed synaptic plasticity in schizophrenia? The evidence, visualisation and modulation.
	William G. Honer, Canada	Chair
	Peter Falkai, Germany	Co-Chair

001	How good is the evidence from post-mortem studies?
	William G. Honer, Canada	Speaker
002	Using in-vivo imaging: Can we see synaptic processes directly?
	Gunther Helms, Germany	Speaker
003	NRG-1, synaptic processes and schizophrenia
	Stephen Lawrie, United Kingdom	Speaker
004	Enhancing synaptic processes via exercise? Is there evidence for schizophrenia?
	Frank-Gerald Pajonk, Germany	Speaker

No.	S-11 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Vigilance regulation in affective disorders
	Ulrich Hegerl, Germany	Chair
	Nathalie Besnier, France	Co-Chair

001	Is mania an autoregulatory attempt to stabilize vigilance and are psychostimulants a treatment option?
	Peter Schönknecht, Germany	Speaker
002	Excessive daytime sleepiness: The role of anxiety, insomnia and depression
	Gregor Hasler, Switzerland	Speaker
003	Vigilance and cognition in bipolar affective disorders
	Nathalie Besnier, France	Speaker
004	Sleep disturbances in patients with affective disorders
	Goeran Hajak, Germany	Speaker

No.	S-12 - Symposium
Time:	11.00-12.30
Room:	Room 251
Topic:	Other
Track:	1 Basic
Session title:	Impulse disorders - categorical versus dimensional approaches: State of the evidence
	Larry Siever, USA	Chair
	Franck Bayle, France	Co-Chair

001	Fractionating impulsivity: Neural and neurochemical perspectives
	Trevor Robbins, United Kingdom	Speaker
002	Brain circuitry and neuromodulators in impulsive aggressive personality disorders
	Larry Siever, USA	Speaker
003	Functional neurocircuitry and neuropsychopharmacology of pathological gambling and the ICD's
	Eric Hollander, USA	Speaker
004	Is ADHD the prototypical impulse control disorder or impulsive facet in ADHD a semantic mistake: Clinical and neuropsychological arguments
	Franck Bayle, France	Speaker

No.	S-14 - Symposium
Time:	14.00-15.30
Room:	Salle Maillot
Topic:	Other
Track:	1 Basic
Session title:	Psychiatric disorders and thyroid axis functioning across lifecycles
	Robertas Bunevicius, Lithuania	Chair
	Peter Whybrow, USA	Co-Chair

001	Thyroid and developing brain
	Victor Pop, Netherlands	Speaker
002	Thyroid hormones in treatment of mood disorders
	Michael Bauer, Germany	Speaker
003	PMDD and thyroid functioning
	Susan Girdler, USA	Speaker
004	Thyroid functioning and mental disorders
	Robertas Bunevicius, Lithuania	Speaker

No.	S-16 - Symposium
Time:	14.00-15.30
Room:	Room 252B
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Advances in the neuroimaging of ADHD
	Joseph Biederman, USA	Chair
	Larry Seidman, USA	Co-Chair

001	Neuroimaging findings implicating fronto-cerebellar circuit abnormalities in the pathophysiology of ADHD
	Eve Valera, USA	Speaker
002	Frontal lobe cortical-limbic deficiencies in adults with ADHD comorbid with bipolar disorder: A cortical thickness MRI analysis
	Nikos Makris, USA	Speaker
003	Pharmacoimaging studies of stimulant formulations in ADHD using positron emission tomography
	Thomas Spencer, USA	Speaker
004	Genetic imaging as a method for identifying pathophysiological heterogeneity in psychiatric disorders: Evidence from ADHD
	Larry Seidman, USA	Speaker

No.	S-21 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Affective Disorders (Unipolar)
Track:	1 Basic
Session title:	Social cognition in depression and suicide: A neuroimaging perspective
	Jonathan Roiser, France	Chair
	Philippe Fossati, France	Co-Chair

001	Self perception in depressed patients and subjects with high risk for depression
	Philippe Fossati, France	Speaker
002	Neural circuits underlying anhedonia in major depressive disorder
	Jonathan Roiser, France	Speaker
003	Is suicide a specific disorder of social cognition?
	Fabrice Jollant, France	Speaker
004	Emotional and social memory
	Martin Lepage, Canada	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	S-27 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) of human brain monoamine neurotransmission
	Nicole Praschak-Rieder, Austria	Chair
	Nathalie Ginovart, Switzerland	Co-Chair

001	Influence of Fenfluramine challenge of Serotonin-2A receptor binding
	Franz Vollenweider, Switzerland	Speaker
002	Effects of SSRIs on brain serotonin function revealed by PET and phfMRI
	Rupert Lanzenberger, Austria	Speaker
003	Brain monoamino-oxidase-A imaging using [11C]harmine and positron emission tomography
	Nathalie Ginovart, Switzerland	Speaker
004	Influence of season and light on human serotonin transporter binding and function
	Matthaeus Willeit, Austria	Speaker

No.	S-28 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Affective Disorders (Unipolar)
Track:	1 Basic
Session title:	Neurobiology of sleep regulation and sleep deprivation and consequences for depression and somatic health
	Axel Steiger, Germany	Chair
	Edith Holsboer-Trachsler, Switzerland	Co-Chair

001	Sleep and neuroendocrine biomarkers as predictors for psychic health and depressive illness course in children and adults
	Martin Hatzinger, Switzerland	Speaker
002	Neuropeptidergic regulation of sleep and sleep deprivation
	Petra Schüssler, Germany	Speaker
003	Neurotransmitter regulation of sleep deprivation in depression
	Ulrich-Michael Hemmeter, Switzerland	Speaker
004	The consequences of chronically disrupted and restricted sleep: Insights from experimental studies in animals and relevance for depression
	Peter Meerlo, Netherlands	Speaker

No.	S-30 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Genetics
Track:	1 Basic
Session title:	Translational research in the neurogenetics of NPY
	Aleksander Mathe, Sweden	Chair
	Andreas Reif, Germany	Co-Chair

001	Distribution of NPY and its receptors: Significance for anxiety/depression and neurogenesis
	Aleksander Mathe, Sweden	Speaker
002	Effects of viral vector-induced overexpression of neuropeptide Y and Y2 receptors in seizure models
	David Woldbye, Denmark	Speaker
003	NPY and its receptor genes in personality disorder
	Andreas Reif, Germany	Speaker
004	Molecular genetic evidence for a 4q31-34 panic disorder risk locus
	Katharina Domschke, Germany	Speaker

No.	S-33 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Other
Track:	1 Basic
Session title:	Peripartum mood disorders: From physiological to pathophysiological adaptations
	Inga D. Neumann, Germany	Chair
	Cort Pedersen, USA	Co-Chair

001	Adaptations of stress responses in peripartum women: Implications for psychiatric illness
	Margaret Altemus, USA	Speaker
002	Late pregnancy thyroid status: Relationships to perinatal depression in women and a rat model
	Cort Pedersen, USA	Speaker
003	Chronic psychosocial stress in pregnancy: Towards an animal model of postpartum depression
	Inga D. Neumann, Germany	Speaker
004	Social support, stress perception and maternal depressive symptoms during pregnancy: Effects on fetal health
	Petra Arck, Germany	Speaker

No.	S-34 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Affective Disorders (Unipolar)
Track:	1 Basic
Session title:	Identifying biomarkers of depression: New insights from animal models
	Igor Branchi, Italy	Chair
	Mathias Schmidt, Germany	Co-Chair

001	Early environment shapes vulnerability to psychopathology in animal models of depression: Is altered metabolism a reliable biomarker?
	Igor Branchi, Italy	Speaker
002	Markers of neuronal network plasticity in mood disorders and antidepressant response
	Eero Castren, Finland	Speaker
003	Novel strategies to discover susceptibility and resilience biomarkers for stress-induced diseases
	Mathias Schmidt, Germany	Speaker
004	From inflammation to depression: A role for indoleamine 2,3 dioxygenase
	Robert Dantzer, USA	Speaker

No.	S-37 - Symposium
Time:	16.00-17.30
Room:	Blue Amphitheatre
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	Psychoses at the interface between neurology and psychiatry
	Michael Trimble, United Kingdom	Chair
	Pierre Flor-Henry, Canada	Co-Chair

001	Epilepsy and psychosis - an epidemiological view
	Dale Hesdorffer, USA	Speaker
002	Psychosis, neurological soft signs and their meaning
	Paola Dazzan, United Kingdom	Speaker
003	Epilepsy and psychosis - anatomy and physiology
	Michael Trimble, United Kingdom	Speaker
004	On the question of the lateralization of epilepsy in the manic-depressive syndrome and depression
	Pierre Flor-Henry, Canada	Speaker

No.	S-39 - Symposium
Time:	16.00-17.30
Room:	Room 352AB
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Genetic and environmental risk factors in early onset bipolar affective disorder
	Frank Bellivier, France	Chair
	Sven Cichon, Germany	Co-Chair

001	Whole genome association studies in bipolar I affective disorder
	Sven Cichon, Germany	Speaker
002	Candidate gene analyses in early onset bipolar affective disorder
	Bruno Etain, France	Speaker
003	Whole genome association analyses in early onset bipolar disorder
	Stephane Jamain, France	Speaker
004	Gene-environment interactions in early onset bipolar disorder
	Frank Bellivier, France	Speaker

No.	S-41 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Brain Function
Track:	1 Basic
Session title:	Metabolism of psychotropic drugs in the human brain: Possible relevance for their clinical profile?
	Pierre Baumann, Switzerland	Chair
	Viji Ravindranath, India	Co-Chair

001	Brain-specific expression of cytochrome P450 enzymes and their impact on metabolism of psychoactive drugs at the site of action
	Viji Ravindranath, India	Speaker
002	Brain Cyp 4Fs in brain injury and psychotropic drug metabolism
	Henry Strobel, USA	Speaker
003	Monoamine oxidase: A challenging enzyme and its drugs
	Peter Riederer, Germany	Speaker
004	Selective metabolism of psychotropic drugs by MAO-A and MAO-B in brain
	Pierre Baumann, Switzerland	Speaker

No.	S-42 - Symposium
Time:	16.00-17.30
Room:	Room 251
Topic:	Neurodegenerative Disorders
Track:	1 Basic
Session title:	Neurobiology of Alzheimer's disease: Beyond the amyloid hypothesis
	Orestes V. Forlenza, Brazil	Chair
	Russell H. Swerdlow, USA	Co-Chair

001	Alzheimer's disease, vascular dementia, or both?
	Donald R. Royall, USA	Speaker
002	The GSK-3 hypothesis of Alzheimer's disease
	Simon Lovestone, United Kingdom	Speaker
003	Phospholipids, phospholipase A2 and membrane abnormalities in Alzheimer's disease
	Wagner F. Gattaz, Brazil	Speaker
004	Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
	Russell H. Swerdlow, USA	Speaker

« previous day	Tuesday, 30. June 2009	next day »

No.	S-46 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Addictive Disorders
Track:	1 Basic
Session title:	Dysregulation of neurogenesis in the brain action: The common mechanism of alcoholism and depression
	Toshikazu Saito, Japan	Chair
	Stefan Brene, Sweden	Co-Chair

001	Stem cells and alcohol dependence: Suppressed neurogenesis after long periods of abstinence
	Anita C. Hansson, Germany	Speaker
002	Depending on dose and context, alcohol consumption can both increase and decrease hippocampal neurogenesis in rodents
	Stefan Brene, Sweden	Speaker
003	Effects of chronic ethanol exposure on long-term differentiation of SH-SY5Y human neuroblastoma cells
	Julian D. Hellmann, Germany	Speaker
004	Potential regulation of neurogenesis by psychotropics in the damaged brain by ethanol
	Eri Hashimoto, Japan	Speaker

No.	S-48 - Symposium
Time:	08.00-09.30
Room:	Room 251
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	New findings on the neurobiological basis of language abnormalities in schizophrenia
	Werner Strik, Switzerland	Chair
	Robert McCarley, USA	Co-Chair

001	Contribution of gene-brain interaction to language abnormalities in schizophrenia
	Tilo Kircher, Germany	Speaker
002	Disordered thought and impaired connectivity of language regions in schizophrenia
	Robert McCarley, USA	Speaker
003	Abnormalities of the language circuitry in schizophrenic thought disorders and hallucinations
	Werner Strik, Switzerland	Speaker
004	Language deficits in schizophrenia: Evidence from behavioral, functional and connectivity studies
	Ruben Gur, USA	Speaker

No.	S-50 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	Microglia in psychiatric disorders
	Natalia Uranova, Russia	Chair
	Norbert Müller, Germany	Co-Chair

001	Microglia as an immune source: The possible role in schizophrenia and depression
	Norbert Müller, Germany	Speaker
002	Glial Cell Changes and Gene expression in the Brain and Blood in Schizophrenia
	Ian Everall, USA	Speaker
003	The distribution of microglia in post-mortem brains of patients with schizophrenia and depression
	Johann Steiner, Germany	Speaker
004	Ultrastructural abnormalities of microglial cells in post-mortem brains in schizophrenia
	Natalia Uranova, Russia	Speaker

No.	S-53 - Symposium
Time:	11.00-12.30
Room:	Room 251
Topic:	Anxiety
Track:	1 Basic
Session title:	Neurobiological correlates of dissociation and influence on information processing in stress-related disorders
	Eric Vermetten, Netherlands	Chair
	Petra Ludäscher, Germany	Co-Chair

001	Neural correlates of dissociation in patients with posttraumatic stress disorder
	Eric Vermetten, Netherlands	Speaker
002	The neural correlates of emotional distraction during working memory performance in traumatized patients with borderline personality disorder
	Annegret Krause, Germany	Speaker
003	Influence of dissociation on information processing in stress-related disorders
	Jana Mauchnik, Germany	Speaker
004	Neural correlates of dissociation in patients with borderline personality disorder
	Ruth Lanius, Canada	Speaker

No.	S-54 - Symposium
Time:	16.00-17.30
Room:	Blue Amphitheatre
Topic:	Neurodegenerative Disorders
Track:	1 Basic
Session title:	Aß Immunotherapy of Alzheimer's disease
	Siegfried Kasper, Austria	Chair
	Serge Gauthier, Canada	Co-Chair

001	Selection of efficacy outcomes in disease-modifying trials that are meaningful to clinicians, patients and payers
	Serge Gauthier, Canada	Speaker
002	Biomarkers in Alzheimer's disease: Use for clinical trials
	Anton Alvarez, Spain	Speaker
003	AD vaccines: The new generation - successes and challenges on its way into clinical practice
	Achim Schneeberger, Austria	Speaker
004	AFFITOPES of Aß as active vaccines in the treatment of AD: results of a phase I study with AFFITOPE AD02
	Alexandra Kutzelnigg, Austria	Speaker

No.	S-55 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	EEG and MEG response to mismatch stimuli as an index of schizophrenia neurobiology and genetics
	Robert McCarley, USA	Chair
	Kiyoto Kasai, Japan	Co-Chair

001	Mismatch negativity from the prodrome to chronicity: Relationships with functional status, generator sources and grey matter loss
	Pat Michie, Australia	Speaker
002	Deficits in primary auditory cortex circuits in subjects with schizophrenia: Matching up with mismatch negativity
	Robert Sweet, USA	Speaker
003	MEG mismatch abnormalities to speech sounds in schizophrenia: Heritability and relationship to genetics
	Tsuyoshi Araki, Japan	Speaker
004	Mismatch negativity is associated with genetic, clinical, cognitive, and functional abnormalities of schizophrenia patients
	Gregory Light, USA	Speaker

No.	S-58 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Are there really progressive brain abnormalities in association with schizophrenia? Current longitudinal magnetic resonance imaging studies from at ri
	Geraldo F. Busatto, Brazil	Chair
	René Kahn, Netherlands	Co-Chair

001	Progressive brain changes across the transition to psychosis: Where to from here?
	Stephen J. Wood, Australia	Speaker
002	Brain changes 6 years after the first episode of a psychosis
	Paola Dazzan, United Kingdom	Speaker
003	Brain changes in schizophrenia across the age range
	René Kahn, Netherlands	Speaker
004	Longitudinal MRI investigation of brazilians with first-onset psychosis over 4 years
	Maristela Schaufelberger, Brazil	Speaker

« previous day	Wednesday, 1. July 2009	next day »

No.	S-61 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Genetics
Track:	1 Basic
Session title:	The genetics of unipolar depression and bipolar affective disorder
	Alexandra Schosser, United Kingdom	Chair
	Peter McGuffin, United Kingdom	Co-Chair

001	The uses and abuses of genome wide linkage and association studies
	Peter McGuffin, United Kingdom	Speaker
002	Genome-wide association studies of bipolar disorder
	Nick Craddock, United Kingdom	Speaker
003	Genetics of bipolar affective disorder
	Markus M. Nöthen, Germany	Speaker
004	A genome wide association study of unipolar depression
	Sarah Cohen-Woods, United Kingdom	Speaker

No.	S-64 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Addictive Disorders
Track:	1 Basic
Session title:	Brain imaging in addiction
	David A. Gorelick, USA	Chair
	Aviv Weinstein, Israel	Co-Chair

001	Role of dopamine in human drug self-administration
	Marco Leyton, Canada	Speaker
002	Role of brain mu-opioid receptors in cocaine addiction
	David A. Gorelick, USA	Speaker
003	Brain serotonin function in MDMA (ecstasy) users
	Franz Vollenweider, Switzerland	Speaker
004	Brain imaging studies of cognitive effects of recreational drugs
	Aviv Weinstein, Israel	Speaker

No.	S-66 - Symposium
Time:	11.00-12.30
Room:	Blue Amphitheatre
Topic:	Neuroimaging
Track:	1 Basic
Session title:	More insight into auditory verbal hallucinations
	Andre Aleman, Netherlands	Chair
	Iris Sommer, Netherlands	Co-Chair

001	Auditory hallucinations and perceptual mechanisms
	Peter Woodruff, United Kingdom	Speaker
002	Cerebral activity before and during auditory verbal hallucinations
	Iris Sommer, Netherlands	Speaker
003	Self-monitoring and inner speech models of AVH; Is there any evidence?
	Paul Allen, United Kingdom	Speaker
004	Right temporoparietal junction and spatial
	Marion Plaze, France	Speaker

No.	S-67 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Neuroimaging the impulsivity in psychiatry
	Pascale Mazzola-Pomietto, France	Chair
	Eric Hollander, USA	Co-Chair

001	Ventral striatum and impulsivity: fMRI in pathological gambling, OCD, and autism
	Eric Hollander, USA	Speaker
002	Functional neural correlates of inhibitory control in mania and schizophrenia
	Arthur Kaladjian, France	Speaker
003	Genetic and disease related impact on the neural correlates of response inhibition in bipolar disorder
	Sophia Frangou, United Kingdom	Speaker
004	Functional correlates of cognitive control in children with attention-deficit hyperactivity disorder and their unaffected siblings
	Martijn Mulder, Netherlands	Speaker

No.	S-68 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Anxiety
Track:	1 Basic
Session title:	The cortical-striatal network in obsessive-compulsive disorder and depression
	Martijn Figee, Netherlands	Chair
	Donald Malone, USA	Co-Chair

001	Limbic-prefrontal control is improved in paroxetine responders, but the ventral striatum is also involved in SSRI-response
	H.G. Ruhe, Netherlands	Speaker
002	The effects of ventral capsule/ventral striatum stimulation in depression
	Donald Malone, USA	Speaker
003	Imaging neurotransmission in the cortical-striatal network of OCD
	Martijn Figee, Netherlands	Speaker
004	Disinhibition of frontal-striatal circuits in the compulsive-impulsive spectrum
	Odile A. van den Heuvel, Netherlands	Speaker

No.	S-69 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Psychopharmacology
Track:	1 Basic
Session title:	Promises and pitfalls of genetic research in drug treatment of depression and schizophrenia
	Daniel J. Mueller, Canada	Chair
	James L. Kennedy, Canada	Co-Chair

001	Results from a whole genome association study in depression: Will putative etiologic genes predict antidepressant response?
	Pierandrea Muglia, United Kingdom	Speaker
002	Impact of MAOA-, COMT- and serotonergic system gene variants in antidepressant drug treatment
	Katharina Domschke, Germany	Speaker
003	Pharmacogenetics of antidepressants in mood disorders, what can be improved? A proposal for methodological guidelines
	Alessandro Serretti, Italy	Speaker
004	Pharmacogenetics of antipsychotics using an animal model
	Dan Rujescu, Germany	Speaker

No.	S-70 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Brain Function
Track:	1 Basic
Session title:	Glia cell pathology in psychiatric disorders
	Matthias Rothermundt, Germany	Chair
	Damir Janigro, USA	Co-Chair

001	Glial changes in post mortem brains of individuals with psychiatric disorders
	Johann Steiner, Germany	Speaker
002	Astroglial antioxidant defense alteration in bipolar disorder
	Carlos Alberto Goncalves, Brazil	Speaker
003	Inflammatory markers in children and adolescents with psychotic disorders, the role of glia cells
	Tatiana Falcone, USA	Speaker
004	Glial activation in psychiatric disorders
	Matthias Rothermundt, Germany	Speaker

No.	S-71 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Catatonia: An update
	Pierre Thomas, France	Chair
	David Cohen, France	Co-Chair

001	Introduction
	Pierre Thomas, France	Speaker
002	Child and adolescent catatonia is associated with an increase in mortallity and morbidity: Evidence from a prospective follow-up study
	David Cohen, France	Speaker
003	Catatonic syndrome in liaison psychiatry: An overview
	Olivier Cottencin, France	Speaker
004	Pathophysiology and the orbitofrontal cortex in Catatonia
	Georg Northoff, Germany	Speaker

No.	S-72 - Symposium
Time:	16.00-17.30
Room:	Room 352AB
Topic:	Other
Track:	1 Basic
Session title:	Recent advances of psychoneuroimmunological study of psychiatric disorders
	Brian E. Leonard, Ireland	Chair
	Shigenobu Kanba, Japan	Co-Chair

001	Anti-inflammatory effects of antidepressants: Implications for pathophysiology of depression
	Akira Monji, Japan	Speaker
002	The mild encephalitis-hypothesis - new findings and studies
	Karl Bechter, Germany	Speaker
003	The role of antiinflammatory therapy in psychiatry
	Norbert Müller, Germany	Speaker
004	Stress and immune markers in depression
	Ted Dinan, Ireland	Speaker

No.	S-73 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Childhood Adolescent Disorder
Track:	1 Basic
Session title:	Biological child and adolescent psychiatry
	Manfred Gerlach, Germany	Chair
	Johannes Thome, United Kingdom	Co-Chair

001	Neurobiology of child and adolescent ADHD
	Marcel Romanos, Germany	Speaker
002	Proteomic research in autism
	Johannes Thome, United Kingdom	Speaker
003	Genetics of early-onset obsessive compulsive disorders
	Susanne Walitza, Switzerland	Speaker
004	Potential biological markers of early-onset schizophrenia
	Claudia Mehler-Wex, Germany	Speaker

No.	S-75 - Symposium
Time:	16.00-17.30
Room:	Room 251
Topic:	Genetics
Track:	1 Basic
Session title:	Recent advances in the neurobiology of suicide
	Kees van Heeringen, Belgium	Chair
	Dan Rujescu, Germany	Co-Chair

001	Separating effects of genes and stress on the neurobiology of suicidal behavior
	Leo Sher, USA	Speaker
002	Early life adversity, biological modifications and impulsive-aggressive suicide
	Gustavo Turecki, Canada	Speaker
003	Orbitofrontal cortex, decision-making and suicidal behaviour
	Fabrice Jollant, France	Speaker
004	Genetics of aggressive and impulsive behavior
	Dan Rujescu, Germany	Speaker

« previous day	Thursday, 2. July 2009

No.	S-76 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	1 Basic
Session title:	Neuroanatomical aspects of prepulse inhibition in schizophrenia: Animal models and human psychoses
	Rainer Wolf, Germany	Chair
	Georg Juckel, Germany	Co-Chair

001	Reduction of prepulse inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats
	Rainer Wolf, Germany	Speaker
002	Perinatal hypoxia as probable animal model of schizophrenia
	Andrea Schmitt, Germany	Speaker
003	Pharmacological studies of prepulse inhibition models of schizophrenia
	Maarten van den Buuse, Australia	Speaker
004	Brain imaging (fMRI) studies of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics
	Veena Kumari, United Kingdom	Speaker

No.	S-79 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Paralimbic determinations and developmental psychiatry
	Jean-Luc Martinot, France	Chair
	Philip McGuire, France	Co-Chair

001	Cortex gyrification in schizophrenia and bipolar patients
	Arnaud Cachia, France	Speaker
002	Pharmaceutical challenges and at-risk subjects
	Philip McGuire, France	Speaker
003	Addiction imaging implication for prevention
	Jean-Luc Martinot, France	Speaker
004	Cognitive reserve Alzheimer's disease and temporal
	David Bartres'Faz, Spain	Speaker

No.	S-80 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	The neural bases of hallucinations in schizophrenia: Recent advances in research
	Kevin Spencer, USA	Chair
	Daniel Mathalon, USA	Co-Chair

001	Hallucination symptoms and oscillatory brain dynamics in schizophrenia
	Kevin Spencer, USA	Speaker
002	Corollary discharge dysfunction in Schizophrenia
	Judith Ford, USA	Speaker
003	Relation beween functional and structural cerebral changes in auditory verbal hallucinations
	Thomas Dierks, Switzerland	Speaker
004	Probing the pathophysiology of auditory/verbal hallucinations by combining fMRI and rTMS
	Ralph Hoffman, USA	Speaker

No.	S-81 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Brain Function
Track:	1 Basic
Session title:	Social cognition, social hormones and psychophathology
	Richard Ebstein, Israel	Chair
	Andreas Meyer-Lindenberg, Germany	Co-Chair

001	Neural and genetic mechanisms of human social behavior
	Andreas Meyer-Lindenberg, Germany	Speaker
002	Neuroanatomical bases of envy and gloating (schadenfreude)
	Simone Shamay-Tsoory, Israel	Speaker
003	The neuroendocrinology of social cognition
	Markus Heinrichs, Switzerland	Speaker
004	Genetics of social cognition
	Salomon Israel, Israel	Speaker

No.	S-82 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	Auditory sensory gating in schizophrenia: Towards a better understanding of the genetical, neurophysiological, and neurochemical underpinnings
	Anke Brockhaus-Dumke, Germany	Chair
	Nash Boutros, USA	Co-Chair

001	Clinical correlates of N100 gating deficit in schizophrenia
	Nash Boutros, USA	Speaker
002	Role of the frontal cortex in both auditory and somatosensory habituation: An MEG study
	Susan Bowyer, USA	Speaker
003	The neurochemical basis of sensory gating in humans
	Maarten van den Buuse, Australia	Speaker
004	Time-frequency analysis of auditory sensory gating in first episode patients and subjects at risk
	Anke Brockhaus-Dumke, Germany	Speaker

No.	S-85 - Symposium
Time:	11.00-12.30
Room:	Room 251
Topic:	Neuroimaging
Track:	1 Basic
Session title:	New imaging evidence for illness progression throughout the course of schizophrenia
	Serge Mitelman, USA	Chair
	Monte Buchsbaum, USA	Co-Chair

001	Morphometric evidence of illness progression in schizophrenia
	René Kahn, Netherlands	Speaker
002	Diffusion tensor imaging tractography in schizophrenia
	Thomas Whitford, USA	Speaker
003	Structural brain changes during transition-to-illness phase in individuals at risk for schizophrenia
	Christos Pantelis, Australia	Speaker
004	A longitudinal study of white matter morphometry and organization in chronic schizophrenia
	Serge Mitelman, USA	Speaker

No.	S-86 - Symposium
Time:	14.00-15.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	1 Basic
Session title:	Neural circuitry and mood disorders: Relationship to course of illness and treatment outcome
	Russell Joffe, USA	Chair
	Thomas Frodl, Germany	Co-Chair

001	Neural circuitry in depression: Concepts and rationale
	Russell Joffe, USA	Speaker
002	Hippocampal volumes predict remission rates early in the course of depression
	Glenda MacQueen, Canada	Speaker
003	Has depression-related decline of brain morphology an impact on illness course?
	Thomas Frodl, Germany	Speaker
004	Towards the development of neurobiological predictors of treatment response: Studies in neuroimaging
	Cynthia Fu, United Kingdom	Speaker

No.	S-88 - Symposium
Time:	14.00-15.30
Room:	Room 352AB
Topic:	Anxiety
Track:	1 Basic
Session title:	Recent advances in neuropharmacology of stress
	Noppamars Wongwitdecha, Thailand	Chair
	Mitsuhiro Yoshioka, Japan	Co-Chair

001	Early life stress modifies the effects of 5-HT1A agonist, 8-OH-DPAT in animal tests of anxiety and depression
	Noppamars Wongwitdecha, Thailand	Speaker
002	Early postnatal stress disturbs normal development of the serotonergic neurons in the raphe nuclei
	Mitsuhiro Yoshioka, Japan	Speaker
003	Pros and cons of stress on the development of social behavior
	Shun Nakamura, Japan	Speaker
004	Behavior recognition technology application in neuropharmacology of stress
	Yiqing Liang, USA	Speaker

No.	S-89 - Symposium
Time:	14.00-15.30
Room:	Room 252B
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	New insights into abnormal neural oscillations in schizophrenia and the structural and receptor basis of the abnormal neural circuitry
	Robert McCarley, USA	Chair
	Toshiaki Onitsuka, Japan	Co-Chair

001	Gamma band and MRI structural abnormalities in first episode schizophrenia and mania
	Robert McCarley, USA	Speaker
002	Abnormal neural oscillatory activity to speech sounds in schizophrenia: An MEG study
	Toshiaki Onitsuka, Japan	Speaker
003	High-frequency oscillations during perceptual organisation in first-episode and chronic schizophrenia
	Peter Uhlhaas, Germany	Speaker
004	N-methyl-D-aspartic acid receptor antagonist induced frequency oscillations in mice recreates pattern of electrophysiological deficits in schizophrenia
	Steven Siegel, USA	Speaker

« Back

---